ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,916, issued on June 10, was assigned to Medtronic Inc. (Minneapolis).
"Hybrid control policy for ECAP-servoed neuromodulation" was invented by David A. Dinsmoor (North Oaks, Minn.) and Kristin N. Hageman (Dayton, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems, devices, and techniques for adjusting electrical stimulation are described. For example, processing circuitry is configured to receive, via a sensing electrode located at a target region of a patient, a plurality of evoked compound action potential (ECAP) signals elicited from respective electrical stimuli delivered to the patient; determine, based on the plurality of ECAP signal...